Fenfluramine in SCN1A-Related Genetic Epilepsy with Febrile Seizures Plus (GEFS+): Toward a Precision Therapeutic Approach
This case highlights the importance of systematic family history and targeted genetic workup in patients with drug-resistant epilepsy, adds preliminary evidence for fenfluramine beyond Dravet and Lennox–Gastaut syndromes, and illustrates the potential of precise genetic diagnosis to guide treatment in SCN1A-related GEF...